Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$6,847,410
+$154,211 QoQ
Shares Held
43,692
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#224
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rathbones Group PLC holds $2,298,575,113 across 12 Drug Manufacturers - General names. NVS ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,979,150 | $1,513,006,423 | |
| 2 | LLY |
ELI LILLY & Co
|
447,654 | $536,929,681 | |
| 3 | JNJ |
Johnson & Johnson
|
691,961 | $175,737,335 | |
| 4 | MRK |
Merck & Co., Inc.
|
207,542 | $26,669,147 | |
| 5 | ABBV |
AbbVie Inc.
|
65,288 | $16,429,072 | |
| 6 | PFE |
Pfizer Inc
|
433,531 | $10,439,426 | |
| 7 | AMGN |
Amgen Inc
|
20,628 | $7,469,811 | |
| 8 | NVS |
Novartis AG
This page
|
43,692 | $6,847,410 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,847,410 | 43,692 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $6,693,199 | 43,818 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $6,342,847 | 46,006 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,930,971 | 46,249 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,880,964 | 48,599 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,456,500 | 48,946 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,950,743 | 50,876 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,464,469 | 56,203 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,181,067 | 58,060 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,772,266 | 59,674 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,234,392 | 61,745 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,600,731 | 64,802 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,115,549 | 60,604 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $5,680,264 | 61,742 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,022,447 | 66,385 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,207,052 | 81,661 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,085,811 | 83,826 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,906,801 | 90,106 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $8,139,695 | 93,057 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,728,128 | 94,499 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $8,641,522 | 94,712 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $8,245,229 | 96,458 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,207,586 | 97,507 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $8,635,475 | 99,304 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,704,915 | 99,667 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $8,244,093 | 99,989 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||